Compare AXGN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | QDEL |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | AXGN | QDEL |
|---|---|---|
| Price | $29.78 | $28.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $33.67 | ★ $39.33 |
| AVG Volume (30 Days) | 992.8K | ★ 1.1M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $214,709,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $21.57 | N/A |
| Revenue Next Year | $15.79 | $2.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.72 | N/A |
| 52 Week Low | $9.22 | $19.50 |
| 52 Week High | $34.24 | $49.45 |
| Indicator | AXGN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 60.09 | 60.27 |
| Support Level | $28.88 | $26.84 |
| Resistance Level | $30.76 | $30.40 |
| Average True Range (ATR) | 1.48 | 1.14 |
| MACD | -0.26 | 0.37 |
| Stochastic Oscillator | 32.64 | 61.52 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.